Why is Titan Biotech falling/rising?

As of 22-Jul, Titan Biotech Ltd is experiencing a decline in its stock price, currently at 446.70, which reflects a decrease of 9.35 or 2.05%. The stock has underperformed its sector today by 1.8% and has been on a consecutive downward trend for the last two days, resulting in a total decline of 2.47% during this period. Additionally, the stock has shown mixed performance over various time frames, with a 1-week return of -1.74% and a 1-month return of +11.15%. However, it has significantly underperformed over the year with a return of -23.50%. The company has reported negative results for the last three consecutive quarters, which has contributed to investor concerns, alongside a high Price to Book Value ratio indicating an expensive valuation compared to peers.
In the broader market context, the Sensex has shown a slight decline of 0.47% over the past week, while Titan Biotech's performance has been notably worse in the same timeframe. The stock's liquidity appears to be decreasing, as evidenced by a 20.2% drop in delivery volume against the 5-day average. Despite having a high return on equity and a low debt-to-equity ratio, the company's poor long-term growth prospects, as indicated by stagnant net sales and operating profits, have led to a lack of investor confidence. This combination of factors has resulted in the stock's recent downward movement, contrasting with the overall market's more stable performance.